Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis Adopts NuGEN's Amplification Tech for Certain GeneChip Analysis

NEW YORK (GenomeWeb News) – Affymetrix service provider Expression Analysis yesterday said it has adopted NuGEN Technologies' Ovation product line for amplifying, fragmenting, and labeling RNA samples for GeneChip array analysis.
 
"We hope to migrate all of our clients who require microarray testing with limited RNA specimens to this service,” Tom Goralski, senior director of laboratory operations at Expression Analysis, said in a statement. “We will continue to evaluate the Ovation system for potential use with whole blood samples."
 
Expression Analysis also said it will begin validating NuGEN’s new WT-Ovation Pico RNA amplification system for ultra-small and/or degraded specimens in early October.
 
"We believe this product may be extremely useful in tumor-based oncology applications," continued Goralski said.
 
Financial terms of the deals were not disclosed.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.